Literature DB >> 11725836

Enterobacterial repetitive intergenic consensus sequence-based PCR (ERIC-PCR); its ability to differentiate Streptococcus pyogenes strains and applicability to the study of outbreaks of streptococcal infection.

M Matsumoto1, Y Suzuki, Y Miyazaki, D Tanaka, T Yasuoka, K Mashiko, R Ishikita, J Baba.   

Abstract

We evaluated the ability of enterobacterial repetitive intergenic consensus sequence-based PCR (ERIC-PCR) to differentiate 95 Streptococcus pyogenes strains with M or T serotypes isolated from sporadic streptococcal infections as compared with M or T serotypings and pulsed-field gel electrophoresis (PFGE). Although the ERIC-PCR had less discriminatory power, defined as the ability to divide the strains with the same serotypes into the different sub-types, than PFGE, it consistently classified the strains into 16 patterns with a high correlation with M or T serotyping. The PCR method further discriminated 4 M or T serotypes into sub-types. The application of ERIC-PCR to 5 outbreaks of streptococcal infection produced the results that agreed closely with those of T serotyping and PFGE. ERIC-PCR has sufficient discriminatory power and is a quick and relatively easy technique, making it useful for routine epidemiological investigations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11725836     DOI: 10.1620/tjem.194.205

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Molecular characterization of hand flora and environmental isolates in a community setting.

Authors:  Preeti Pancholi; Mimi Healy; Tracy Bittner; Renee Webb; Fan Wu; Allison Aiello; Elaine Larson; Phyllis Della Latta
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Molecular typing of colonizing Streptococcus agalactiae strains by enterobacterial repetitive intergenic consensus PCR (ERIC-PCR) in a Chennai based hospital.

Authors:  D K Bishi; S Verghese; R S Verma
Journal:  Indian J Microbiol       Date:  2008-05-28       Impact factor: 2.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.